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Abstract
Background: The standard treatment for new case of drug-susceptible tuberculosis according to WHO recommendations in the Republic of Moldova has 
been performed since 2000 and must achieve a treatment success rate of at least 85%. Actually the treatment success rate has increased due to excluding 
of MDR-TB patients from the general cohort. The major rate of patients with low outcome is represented by died and lost to follow-up cases (drop out).
Material and methods: A retrospective selective, descriptive study targeting social, demographic, economic and epidemiological peculiarities, case-
management, radiological aspects diagnosis and microbiological characteristics of 154 patients with pulmonary tuberculosis was performed.
Results: It was established that the major risk factors for loss of follow-up were: low educational level, homelessness, history of detention, migration 
and delayed patient’s direct addressing the specialized hospital services. The major risk factors for death were: low educational level, homelessness and 
other ways of detection (detection by civic organizations, during specialized consultations in other somatic hospitals) as a result of the unemployment 
and lack of health insurance.
Conclusions: Raising awareness among high risk patients and their families about tuberculosis, emphasizing that the diagnosis and treatment are free 
of charge and independent regarding their social and economical status will improve disease outcome.
Key words: tuberculosis, risk factors.
Introduction
Tuberculosis represents a major global health problem, 
well recognized in the Republic of Moldova [1]. According 
to the WHO report in 2015, 10.4 million new cases were re-
ported worldwide, of which 5,9 million (56%) were among 
men, 5.5 million (34%) among women and 1.0 million (10%) 
among children. From all new tuberculosis cases 1.2 million 
(11%) were people living with HIV. Two thirds of all cases 
were living in 6 countries: India, Indonesia, China, Nigeria, 
Pakistan and South Africa [2,3,4]. In the Republic of Moldova 
4.211 cases were notified in 2015, 3.608 were new cases, 85% 
of them were tested by rapid diagnostic methods, 95% had 
HIV status, 90% had pulmonary tuberculosis and 64% were 
bacteriologically confirmed [1].
The standard treatment for new drug-susceptible tubercu-
losis according to WHO recommendations in the Republic of 
Moldova has been used since 2000 and lasts 6 months. It con-
sists in a two phase regimen with four first-line drugs: isonia-
zid (H), rifampicine (R), ethambutol (E) and pyrazinamide 
(Z) in the intensive phase and two first-line drugs: isoniazid 
and rifampicine in the continuation phase [5]. It costs in av-
erage US$40 per person and must achieve at least 85% treat-
ment success rate.  In the top of causes of death worldwide 
tuberculosis was placed on the 5th place in lower-middle in-
come countries in 2015 [6]. According to the WHO published 
data in 2014 in the Republic of Moldova the drug-susceptible 
treatment success rate in HIV-negative patients constituted 
79%, in HIV-positive cohort 47% and in multidrug resis-
tant tuberculosis (MDR-TB) cohort 53% [4]. The quality of 
TB control activities is demonstrated by the rate of MDR-TB 
cases at the regional level. Globally in 2015 there were esti-
mated 580.000 new MDR-TB cases, but only 125.000 received 
DOTS-Plus regimen [4].  In 2015 in the Republic of Moldova 
32 % (29%–34%) of new cases were MDR-TB and 69% (66%–
72%) of retreated cases were MDR-TB [1]. 
The major determinants of tuberculosis treatment out-
comes are socioeconomic inequalities in health [7]. Public 
health barriers which decrease treatment outcome are: geo-
graphic (long distance, natural barriers), economic (lack of 
social protection and medical insurance) and cultural barriers 
to health care access (stigma, poor housing and environmen-
tal conditions), malnutrition, harmful habits and substances 
abuse (tobacco smoking, alcohol abuse, illicit drug use), eth-
nic group affiliation and continuous contact with an infec-
tious source [8,9]. In consequence, the distribution of low 
tuberculosis outcomes reflects the social determinants with 
impact on late disease diagnosis and treatment onset, poor 
treatment adherence and high rate of side effects [9, 10]. In 
comorbid groups the disease progression and low treatment 
outcome were determined by immune suppressive condi-
tions: HIV-positive status [11,12,13,14], diabetes [15,16], can-
cer [17,18], silicosis [19], chronic respiratory diseases [20], 
gastrointestinal diseases, malnutrition [21], other immune 
suppressive causes (immune modulating drugs, immune 
suppressive therapy, antineoplastic drugs) [22,23,24,25]. The 
most relevant actions for improving the outcome in those pa-
tients must be performed in the frame of general medicine 
network, through the active screening and close follow-up of 
high risk groups [26,27]. In that subgroups the tight network 
between primary health care, tuberculosis specialized insti-
tutions and social services will ensure the highest treatment 
effectiveness [28].
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activities for strengthening tuberculosis control programs, di-
agnostics, treatment and effectiveness of tuberculosis nation-
al policy. World Health Organization, International Union 
against Tuberculosis and Lung Diseases, and UNDP empha-
sized that interventions from outside the health sector, social 
protection and urban planning have the biggest potential to 
increase tuberculosis control. Those organizations recom-
mend to pay attention and to solve social issues of tubercu-
losis patients [5]. Higher rate of low tuberculosis outcomes 
in disadvantaged groups such as in poor, comorbid, addictive 
groups and ethnic minorities demonstrated that inter-sector 
collaboration is underestimated and the community partici-
pation is unsatisfactory [29]. 
In the frame of supportive actions, there were established 
duties of the social worker to be performed within the Na-
tional Tuberculosis Control Programme for assistance of 
tuberculosis patients, their families and other categories of 
population with risks: identifying their social rights, type of 
social assistance and services for promoting social support 
[30, 31]. Starting with obtaining and assistance in identify-
ing documents for the local governmental social services, the 
patients will be assisted in registering in the list of the general 
practitioner, in establishing and maintaining a favorable part-
nership with authorities, municipality and non-governmental 
organizations. In association to the social security options, 
the psychosocial counseling and opportunities to get a free 
medical examination for tuberculosis and associated diseases 
must be provided [32]. 
According to the economical status of tuberculosis pa-
tients there are different possibilities for each patient to en-
sure a high quality adherence to tuberculosis treatment, that 
are more or less satisfied by the local municipality: financial 
assistance – food parcels, travel vouchers, financial support 
[33]. It was well recognized that only governmental-public 
organizations have no sufficient impact on the quality of care 
of tuberculosis patients and treatment outcome. So, all stake-
holders must agree a strong partnership for improving disease 
control including health focused NGOs and other organiza-
tions oriented for serving poor communities, vulnerable sub-
populations, ethnic minorities, migrant workers, etc. [32,34]. 
However, academic institutions, medical and public health 
schools, throughout the scientific programmes must provide 
technical support for analysis of health determinants, epide-
miology and monitoring of high risk patients for establishing 
community-based health projects and improving tuberculosis 
treatment outcome. 
So, the aim of the study was to assess the major determi-
nants of low tuberculosis treatment outcome: death and loss 
to follow-up in the period 2014-2016. Objectives were: 1. 
Assessment of tuberculosis treatment outcome dynamics in 
pulmonary tuberculosis cases registered in Chisinau during 
2011-2015.  2. Assessment of general, socio-economic and ep-
idemiological risk factors of pulmonary tuberculosis patients 
with low treatment outcome (death and loss to follow-up).  3. 
Evaluation of case-management, diagnosis, radiological as-
pects and microbiological characteristics of patients with low 
tuberculosis treatment outcome (death and loss to follow-up). 
4. Establishment of a method for the comprehensive evalua-
tion of risk factors for low treatment outcome (death and loss 
to follow-up).
Material and methods
It was performed a retrospective selective, descriptive 
study targeting social, demographic, economic and epidemi-
ological peculiarities, case-management, diagnosis radiologi-
cal aspects and microbiological characteristics of 154 patients 
with pulmonary tuberculosis registered in Chisinau city. The 
electronic system for monitoring and follow-up of tuberculo-
sis cases (SIME TB) was used for the patients’ selection. Data 
were extracted from the statistic templates F089/1-e “Decla-
ration about patient’s established diagnosis of new case/re-
lapse of active tuberculosis and restart of the treatment and 
its outcomes”. Inclusion criteria were: age > 18 years old, new 
case of pulmonary tuberculosis, signed informed consent. 
New case is the patient never treated for TB or has taken anti-
TB drugs less than one month. The investigational schedule 
included demographic, social and epidemiological data: sex 
(male/female ratio), age (distribution in age groups), demo-
graphic characteristics (urban/rural residence), educational 
level, socio-economic status (employed, unemployed, retired, 
disabled, student), health insurance status (lack or presence 
of insurance),  migration and detention history, presence of 
high risks (close contact with an infectious source, comorbid-
ities: HIV-infection, diabetes, psychiatric diseases, immune 
suppressive treatment), type of infectious cluster, health care 
seeking behavior, way of the patient’s detection. All selected 
patients were diagnosed and managed according to the Na-
tional Clinical Protocol 123 “Tuberculosis in adults”. Enrolled 
patients were distributed in three groups: the 1st group – con-
trol group (1) was constituted of 57 patients successfully treat-
ed (cured) in the period 01.01.2016-31.12.2016, the 2nd group 
– study group (2) was constituted of 22 patients lost to follow-
up in the period of 01.01.2013-31.1201.2016, the 3rd group 
– study group (3) was constituted of 75 patients died during 
the treatment in the period of 01.01.2014-31.12.2016. Statistic 
analysis was carried out using the quantitative and qualitative 
research methods. Statistical survey was performed using Mi-
crosoft Excel XP soft. 
Results and discussion
According to the published data by the Moldovan 
National Centre for Management in Health during the period 
2011-2015 it was registered an important mortality decline 
(with 12,3/100.000) in Chisinau: 2011 – 19,2/100.000, 2012 – 
15,4/100.000, 2013 – 10,8/100.000, 2014 – 10 /100.000, 2015 
– 6,9 /100.000 population. Due to the improving of the treat-
ment quality, the rate of died MDR-TB patients is continu-
ously decreasing: 2011 – 51.7%, 2012 – 47.2%, 2013 – 46%, 
2014 – 34.6%, and 2015 – 23.2%. The treatment success rate 
increased (+33.7%) from 2010 to 2014 in the positive acid 
fast bacilli patients: 2010 – 45%, 2011 – 56.7%, 2012 – 57.5%, 
and in bacteriologically confirmed cases 2013 – 70.3%, 2014 
– 78.7%. The treatment failure rate showed a sharp decrease 
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from 2010 to 2015 due to definition changes: 2010 – 26.9%, 
2011 – 23.6% and 2012 – 18.2%. During this period of time all 
cases identified with MDR-TB and performing drug-suscep-
tible treatment were considered therapeutic failure. Starting 
from 2013 patients with treatment failure were considered 
only patients with microbiological smear positive after 5 
months of treatment. Actually the rate of treatment failure is 
very low: 2013 – 6% and 2014 – 2.8%. The rate of patients lost 
to follow-up decreased evidently: 2010 – 15.8%, 2011 – 16%, 
2012 – 13.7%, 2013 – 9.3% and 2014 – 11.2%.
Clinical study established a similar sex distribution in 
the cured (the 1st group) and lost to follow-up group (the 2nd 
group), with male/female ratio=1,43/1 in the 1st group and 1/1 
in the 2nd group. Comparing control group of cured patients 
(the 1st group) and died patients (the 3rd group) it was estab-
lished a predominance of men in the 3rd group: 62 (82.6%) 
vs. 33 (58.9%) women, with male/female ratio=2,69/1. 
Repartition of the patients into three age groups, identified 
that the largest represented were 18-44 years old in all three 
groups. Comparing the groups it was established that the rate 
of young (18-44 years) patients, economical and reproduc-
tive active people predominated in the 2nd group: 19 (86.3%) 
vs. control group 32 (57.1%). Patients from the age groups 
>45years predominated in the 3rd group without achieving the 
statistical threshold. So, while distributing patients according 
to the biological characteristics it was argued that men and 
women had the same probability to be cured or to default the 
treatment, but men more frequently die due to tuberculosis. 
Demographic distribution identified that all the enrolled 
patients were from the Republic of Moldova and in all groups 
there was a similar proportion of individuals from the urban 
and rural areas. 
Table 1





CG (1) LFUG (2) DG (3)
N=56 
(P %)
N=22 (P %) N=75 (P %)
Sex Men  33 (58,9) 11 (50,0) 62 (82,6) ## 
Women  23 (41,1) 11 (50,0) 13 (17,3) ## 
Age groups 18-44 years  32 (57,1) 19 (86,3) ** 37 (49,3)
45-64 years  13 (32,2) 2 (9,1)  29 (38,6) 
> 65 years  11 (19,6) 1 (4,5) * 9 (12,0)
Residence urban 35 (62,5) 17 (77,3) 50 (66,7)
rural 21 (37,5) 5 (22,7) 25 (33,3)
Note: Applied statistical test: paired simple T-test, P – probability;
Statistically significant differences between: LFUG (2) compared to the 
control group (CG) (1) * – p<0.05; ** – p<0.01; *** – p<0.001; DG (3) 
compared to the control group (CG) (1) # – p<0.05; ## – p<0.01; 
 – p<0.001; LFUG (2) compared to the died group (DG) (3)  – p<0.05; 
 – p<0.01; – p<0.001.
While distributing patients according to the economic sta-
tus, it was established that employed persons, that are contrib-
uting to the health budget by paying taxes, health insurance 
policy and social taxes predominated in the 1st group (con-
trol) comparing with the study groups. Disabled patients in 
all three groups demonstrated that most of them had no social 
protection and financial income. Low rate of retired patients 
was due to the young age of selected patients. Students were 
in a very limited number. Unemployed patients were the ma-
jority of all three groups, but statistically predominated in the 
3rd group. Health insurance represents the major condition 
for accessing health care in the Republic of Moldova. Patients 
without insurance predominated in all study groups compar-
ing with the control one.
Table 2




CG (1) LFUG (2) DG (3)
N=56 (P%) N=22 (P%) N=75 (P%)
Stable Employed 9 (16,1) 1 (1,3) ** 3 (4,0) #
Disabled  1 (1,7) 1 (1,3) 3 (4,0)
Retired 7 (12,5) 3 (4,0)  6 (8,0)
Student 2 (3,6) 1 (1,3) 0
Vulnerable Unemployed 37 (66,1) 16 (72,7) 63 (84,0) #
Lack of 
insurance
35 (62,5) 19 (86,4) *** 61 (81,3) #
Note: Applied statistical test: paired simple T-test, P – probability, 
Statistically significant differences between: LFUG (2) compared to the 
control group (CG) (1) * – p<0.05; ** – p<0.01; *** – p<0.001; DG (3) 
compared to the control group (CG) (1) # – p<0.05; ## – p<0.01; 
### – p<0.001.
Considering these results, mass media must inform gene-
ral population about full accessibility to all related diagnostic 
tools and specific treatment for tuberculosis is free of charge 
for all Moldovan citizens regardless of their health insurance 
and economic status.
Table 3
Distribution of patients according  












Illiteracy No school attendance 0 5 (22,7) ** 4 (5,3)
Primary 
level
Primary & general 
incomplete school 





11 (19,6) 4 (18,2) 27 
(36,0)##
Professional school 15 (26,9) 6 (27,3) 8 (10,7) ##
Higher 
education
Superior studies 5 (8,9) 0 3 (4,0)
Note: Applied statistical test: paired simple T-test, P – probability;
Statistically significant differences between: LFUG (2) compared to the 
control group (CG) (1) * – p<0.05; ** – p<0.01; *** – p<0.001; DG (3) 
compared to the control group (CG) (1) # – p<0.05; ## – p<0.01; 
### – p<0.001. 
Assessing the educational level it was established that most 
of the patients from all three groups graduated primary and 
general incomplete school. However, the completed general 
studies were more frequently identified in the patients from 
the 3rd group comparing with the control group and gradu-
9
10
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ated professional school more frequently patients from the 
control group comparing with the 3rd group. Higher education 
was established in a limited number of cases. So, awareness 
and information about disease signs as well as education for 
risk reduction of persons with low degree of education are the 
most important tools that must be performed by the civil so-
ciety organizations. Exposed data are revealed in the table 4.
Hierarchy of risk groups according to the widest rate of 
patients identified that the biggest impact on the developing 
of active pulmonary tuberculosis in all three groups deter-
mined the patient’s vulnerable economic status and living 
in poor conditions. Extreme poverty (homeless individuals) 
was identified only in the study groups. History of migration 
during last year and history of imprisonment statistically 
predominated in the 2nd group. Low rate of family TB clus-
ters affiliated to each investigated patient in all groups was 
due to the low quality of epidemiological cross-examination, 
rather than to the lack of closed (family) contacts. Patients 
with associated diseases were one third of the 2nd group and 
one half of the 3rd group. Comorbid patients statistically pre-
dominated in the 3rd group comparing with the 2nd group and 
control group. Among associated diseases, HIV infection 
was established in 3 (5.4%) cases of the 1st group, 4 (18.2%) 
cases in the 2nd group and 13 (17.3%) cases in the 3rd group. 
Diabetes was diagnosed only in 1 (1.7%) case of the 1st group. 
Chronic alcoholism was diagnosed in 1 case (1.7%) in the 1st 
group, 4 (18.2%) cases in the 2nd group and 16 cases (21.3%) 
in the 3rd group. Neoplasm was diagnosed only in1 (1.3%) 
case in the 3rd group.
So, the distribution of patients with pulmonary tubercu-
losis with different low outcomes established the primary tar-
get groups in frame of which must be performed awareness, 
education, and improvement of health behavior of social and 
economically vulnerable groups, comorbid groups, migrants 
and homeless people.
Table 4








Risk  groups CG (1) LFUG (2) DG (3)
N=56 (P %) N=22 (P %) N=75 (P %)
Poor living condi-
tions
32 (57,1) 15 (68,1) 52 (69,2)
Homelessness 0 3 (13,6) * 16 (21,3) 
###
Migration 5 (8,9) 7 (31,8) * 3 (4,0) 
History of deten-
tion
0 3 (13,6) * 1 (1,3)




8 (14,3) 6 (27,3) 34 (45,3) 
### 
Note:  SG – social group, EG-epidemiological group, MBG-medico-
biological group.
Applied statistical test: paired simple T-test, P – probability;
Statistically significant differences between: LFUG (2) compared to the 
control group (CG) (1) * – p<0.05; ** – p<0.01; *** – p<0.001; DG (3) 
compared to the control group (CG) (1) # – p<0.05; ## – p<0.01; 
### – p<0.001; LFUG (2) compared to the died group (DG) (3)  – p<0.05; 
 – p<0.01;  – p<0.001.
Studying case-management it was identified that general 
medical staff was involved in the detection of one half of the 
control group and lower rate in study groups. The rate of pa-
tients detected by the passive way based on the microscopic 
examination of the symptomatic cases was statistically higher 
in control than in study groups. The rate of high risk groups 
investigated through active screening was low in all three 
groups that demonstrated low disease control in vulnerable 
populations. Specialized medical staff diagnosed more fre-
quently patients from the 3rd group comparing with the 2nd 
during interdisciplinary consultations. Direct addressing to 
the hospital specialized services was used more frequently by 
the patients from the 2nd group comparing with control and 
the 3rd groups, due to the lack of health insurance and lack 
of direct addressing to the primary health care sector. Other 
ways of detection predominated in the 3rd group comparing 
with the control one. It was used for diagnosis of patients 
hospitalized in somatic clinical hospitals and for detection of 







CG (1) LFUG (2) DG (3)
N=56 
(P %)
N=22 (P %) N=75 (P %)




























11 (50,0) ### 16 (21,3) 
Other Other ways 0 3 (13,6) 20 (26,7)  ###
Note: Applied statistical test: paired simple T-test, P – probability;
PHC-primary health care, GPs-general practitioners, SP-specialist 
pneumophtysiologist.
Statistically significant differences between: LFUG (2) compared to the 
control group (CG) (1) * – p<0.05; ** – p<0.01; *** – p<0.001; DG (3) 
compared to the control group (CG) (1) # – p<0.05; ## – p<0.01; 
### – p<0.001; LFUG (2) compared to the died group (DG) (3)  – p<0.05; 
 – p<0.01;  – p<0.001.
Identifying the clinical radiological forms of pulmonary 
tuberculosis it was established that infiltrative opacities pre-
vailed in the control group comparing with study groups. 
Appreciating clinical radiological forms it was established 
that the majority of cases had pulmonary infiltrative tuber-
culosis. Other radiological forms: disseminated tuberculosis 
prevailed in the 3rd group comparing with the 1st group and 
fibro-cavernous tuberculosis in the 2nd group comparing with 
the 1st group. Distributing patients according to the number 
of the affected lungs it was established that one lung was in-
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volved in two thirds of the 1st and the 2nd group and both lungs 
were affected in two thirds of the 3rd group. Destructive forms 
of pulmonary tuberculosis were identified more frequently in 
the 3rd group comparing with the 2nd group. Extensive forms 
of pulmonary tuberculosis affecting 3 and more lung seg-
ments predominated in the 3rd group comparing with the 1st 













Forms of TB PIT 54 (96,4) 17 (77,3) * 57 (76,0)  ##
PDT 2 (3,6) 2 (9,1) 13 (17,3) 
FCVT 0 3 (13,6) * 5 (6,7)
Localization 1 lung 38 (67,8) 16 (72,7) 19 (25,3) ) ### 








6 (27,3) 45 (60,1) ###
Note: PIT- pulmonary infiltrative tuberculosis, PDT- pulmonary 
disseminated tuberculosis;
FCVT- pulmonary fibro-cavernous tuberculosis;
Statistically significant differences between: LFUG (2) compared to the 
control group (CG) (1) * – p<0.05; ** – p<0.01; *** – p<0.001; DG (3) 
compared to the control group (CG) (1) # – p<0.05; ## – p<0.01; 
### – p<0.001; LFUG (2) compared to the died group (DG) (3)  – p<0.05; 

























43 (76%) 12 (54,5) *** 34 (45,3) ###
GeneXpert 
MTB/Rif
Sensible 43 (100%) 8 (66,7) 26 (76,5)
Resistant 0 4 (33,7) 8 (33,5)
Note: Applied statistical test: paired simple T-test, P – probability;
Statistically significant differences between: LFUG (2) compared to the 
control group (CG) (1) * – p<0.05;
** – p<0.01; *** – p<0.001; DG (3) compared to the control group (CG) 
(1) # – p<0.05; ## – p<0.01; ### – p<0.001; LFUG (2) compared to the 
died group (DG) (3)  – p<0.05;  – p<0.01;  – p<0.001.
When assessing the laboratory features of the enrolled 
cured new pulmonary tuberculosis cases, it was identified 
that one half of patients were microscopic positive for acid-
fast-bacilli, 35 (62%) were identified to have positive bacte-
riological results (culture on solid Lowenstein-Jensen ether 
liquid MGIT BACTEC). The sensibility to the rifampicine 
through GeneXpert MTB/Rif assay was established positive 
in the entire control group. Drug sensitivity testing identified 
mono-resistance to isoniazid in 1 patient, poli-resistance to 
isoniazid and streptomycine in 3 cases and monoresistance to 
streptomycine in 1 case. In the 2nd and the 3rd group only every 
fifth patient was microbiological positive, due to the short du-
ration of hospitalization. In the 2nd group were identified 4 pa-
tients with MDR-TB and there were no patients with mono- 
and poliresistance. In the 3rd group were identified 2 patients 
with MDR-TB and there were no patients with mono- and 
poliresistance.
An important research outcome represents the relative 
risk (RR), odds ratio (OR) and attributable risk (AR) indices 
for identifying the priority interventions in the frame of spe-
cific subgroups for low outcome. In the table 8 were repre-
sented only risk factors and features which predominated and 
exposed statistical difference between lost to follow-up and 
control groups. It was established that major risk factors for 
loss to follow-up were: low level of education, patient’s home-
less state and history of detention, followed by the migration 
and direct addressing to the specialized hospital services due 
to the lack of referral general practitioner and other socio-
economical vulnerable characteristics. 
Table 8














Homelessness 2,67-5,82 N/A 100%
Migration 1,35-5,01 1,34-17,51 72%
History of detention 2,71-5,91 N/A 100%
Case-mana-
gement





Note: RR-relative risk, OR-odds ratio; AR-attributable risk, N/A-non 
available.
Table 9











1,68 (1,05-2,69) 2,83 (1,25-6,46) 21%
Lack of insur-
ance
1,58 (1,03-2,45) 2,61 (1,18-5,78) 23%
Low educa-
tional level
1,81 (1,54-2,11) N/A 100%






1,75 (1,34-2,29) 4,97 (2,07-11,94) 69%
Other way of 
detection
2,02 (1,67-2,43) N/A 100%
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The next table reflects data assessing risk factors and fea-
tures which statistically predominated in the group of died 
patients comparing with the control group. It was established 
that major risk factors for death were similar as with those 
that determined the drop up: low level of education, home-
lessness and ways of detection other than passive and active 
way according to the national policy, and unemployment that 
was associated to the social vulnerability.
Conclusions
 The standard treatment for new case of drug-susceptible 
tuberculosis according to WHO recommendations in the 
Republic of Moldova has been performed since 2000, lasts 6 
months, consists in a two phase regimen and must achieve a 
treatment success rate of at least 85%.
 The treatment success rate increased in last 5 years due to 
excluding of MDR-TB cohort from the assessed cohort.
 Actually, the major rate of patients with low outcome is 
represented by died and lost to follow-up cases.
 Comparing the control group consisting of cured pa-
tients and the study group that dropped out it was identified 
that major risk factors for loss to follow up were: low educa-
tional level, homelessness and history of detention, migration 
and direct addressing to the specialized hospital services.
 Comparing the control group consisting of cured pa-
tients and the study group of died patients it was identified 
that major risk factors for death were: low educational lev-
el, homelessness and other ways of detection (detection by 
NGOs, specialized consultations in other somatic hospitals) 
as a result of the unemployment and lack of health insurance.
 Raising awareness among socially vulnerable groups 
and their families about tuberculosis, emphasizing that the 
diagnosis and treatment are free of charge and independent 
regarding their social status will improve treatment outcome 
and disease control at the local level.
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